Low-dose esketamine administered post-labor significantly reduced depressive symptoms in women with prenatal depression within 42 days, despite an increase in short-lived neuropsychiatric side effects.
Esketamine after childbirth cuts risk of postnatal depression by three-quarters
- Post author:
- Post published:April 14, 2024
- Post category:uncategorized